LM FUNDING AMERICA, INC. (LMFA): Nasdaq/NYSE listing notice — LM Funding receives Nasdaq minimum bid price deficiency notice; 180-day cure period until Oct 11, 2023

LM FUNDING AMERICA, INC.

Bid price below $1.00 for 30 consecutive business days as of April 13, 2023.
Automatic 180-day grace period until October 11, 2023 to regain compliance by closing at $1.00 for 10 consecutive days.
If not cured, may qualify for second 180-day period by meeting other listing standards and notifying Nasdaq of intent to cure.
Non-compliance does not affect business operations or SEC reporting requirements.
No assurance of regaining compliance; delisting possible if not cured.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

LM FUNDING AMERICA, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

April 14, 2023, LM Funding America, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company’s consolidated closing bid price has been below $1.00 per share for 30 consecutive business days as of April 13, 2023, and that, therefore, the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which is the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. Pursuant to Nasdaq Listing Rule

View on SEC.gov

2 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

LM FUNDING AMERICA, INC. filing history →

Source: SEC EDGAR

accession 0000950170-23-012987

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.